中外製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/02/15 | 3,946 | 3,983 | 3,933 | 3,961 | +6 | +0.2% | 1,728,200 |
2022/02/14 | 3,980 | 4,014 | 3,931 | 3,955 | -116 | -2.8% | 2,058,200 |
2022/02/10 | 4,116 | 4,183 | 4,053 | 4,071 | -29 | -0.7% | 2,673,200 |
2022/02/09 | 4,092 | 4,123 | 4,073 | 4,100 | -6 | -0.1% | 2,741,500 |
2022/02/08 | 4,042 | 4,120 | 4,032 | 4,106 | +47 | +1.2% | 2,387,100 |
2022/02/07 | 3,977 | 4,068 | 3,957 | 4,059 | +79 | +2% | 2,491,100 |
2022/02/04 | 3,830 | 4,019 | 3,808 | 3,980 | +177 | +4.7% | 4,367,900 |
2022/02/03 | 3,815 | 3,845 | 3,777 | 3,803 | -17 | -0.4% | 1,721,300 |
2022/02/02 | 3,788 | 3,845 | 3,769 | 3,820 | +102 | +2.7% | 2,104,200 |
2022/02/01 | 3,706 | 3,747 | 3,677 | 3,718 | +7 | +0.2% | 1,840,500 |
2022/01/31 | 3,746 | 3,746 | 3,668 | 3,711 | -38 | -1% | 2,190,100 |
2022/01/28 | 3,629 | 3,762 | 3,616 | 3,749 | +188 | +5.3% | 2,569,200 |
2022/01/27 | 3,693 | 3,693 | 3,545 | 3,561 | -136 | -3.7% | 2,488,900 |
2022/01/26 | 3,700 | 3,729 | 3,670 | 3,697 | -1 | ±0% | 1,881,300 |
2022/01/25 | 3,730 | 3,739 | 3,676 | 3,698 | +6 | +0.2% | 2,598,500 |
2022/01/24 | 3,658 | 3,719 | 3,652 | 3,692 | +12 | +0.3% | 1,501,800 |
2022/01/21 | 3,674 | 3,697 | 3,637 | 3,680 | -9 | -0.2% | 2,126,900 |
2022/01/20 | 3,636 | 3,711 | 3,623 | 3,689 | +53 | +1.5% | 1,756,900 |
2022/01/19 | 3,710 | 3,723 | 3,616 | 3,636 | -97 | -2.6% | 2,047,200 |
2022/01/18 | 3,748 | 3,748 | 3,694 | 3,733 | -4 | -0.1% | 1,364,000 |
2022/01/17 | 3,783 | 3,805 | 3,726 | 3,737 | -13 | -0.3% | 1,160,000 |
2022/01/14 | 3,694 | 3,750 | 3,686 | 3,750 | +19 | +0.5% | 2,737,200 |
2022/01/13 | 3,810 | 3,816 | 3,727 | 3,731 | -94 | -2.5% | 1,828,500 |
2022/01/12 | 3,778 | 3,868 | 3,761 | 3,825 | +56 | +1.5% | 2,253,600 |
2022/01/11 | 3,738 | 3,769 | 3,686 | 3,769 | +44 | +1.2% | 2,106,800 |
2022/01/07 | 3,741 | 3,766 | 3,672 | 3,725 | -9 | -0.2% | 2,622,100 |
2022/01/06 | 3,797 | 3,824 | 3,734 | 3,734 | -61 | -1.6% | 2,164,600 |
2022/01/05 | 3,834 | 3,842 | 3,786 | 3,795 | -33 | -0.9% | 2,069,700 |
2022/01/04 | 3,770 | 3,839 | 3,714 | 3,828 | +93 | +2.5% | 1,959,600 |
2021/12/30 | 3,765 | 3,789 | 3,735 | 3,735 | -37 | -1% | 1,555,700 |
2021/12/29 | 3,764 | 3,801 | 3,742 | 3,772 | -25 | -0.7% | 1,185,700 |
2021/12/28 | 3,737 | 3,808 | 3,736 | 3,797 | +50 | +1.3% | 1,583,200 |
2021/12/27 | 3,740 | 3,772 | 3,728 | 3,747 | -22 | -0.6% | 1,339,300 |
2021/12/24 | 3,750 | 3,775 | 3,738 | 3,769 | +19 | +0.5% | 1,094,400 |
2021/12/23 | 3,728 | 3,750 | 3,705 | 3,750 | +8 | +0.2% | 1,148,900 |
2021/12/22 | 3,703 | 3,748 | 3,702 | 3,742 | +42 | +1.1% | 1,759,400 |
2021/12/21 | 3,679 | 3,712 | 3,650 | 3,700 | +83 | +2.3% | 2,216,500 |
2021/12/20 | 3,612 | 3,676 | 3,591 | 3,617 | +5 | +0.1% | 2,576,500 |
2021/12/17 | 3,694 | 3,720 | 3,612 | 3,612 | -198 | -5.2% | 4,377,800 |
2021/12/16 | 3,836 | 3,836 | 3,777 | 3,810 | +66 | +1.8% | 2,728,600 |
2021/12/15 | 3,770 | 3,777 | 3,727 | 3,744 | -33 | -0.9% | 2,278,700 |
2021/12/14 | 3,838 | 3,838 | 3,744 | 3,777 | +30 | +0.8% | 2,706,500 |
2021/12/13 | 3,788 | 3,796 | 3,731 | 3,747 | +47 | +1.3% | 1,662,200 |
2021/12/10 | 3,761 | 3,771 | 3,693 | 3,700 | -90 | -2.4% | 3,209,400 |
2021/12/09 | 3,838 | 3,848 | 3,787 | 3,790 | -84 | -2.2% | 2,349,500 |
2021/12/08 | 3,788 | 3,904 | 3,769 | 3,874 | +246 | +6.8% | 3,830,100 |
2021/12/07 | 3,598 | 3,658 | 3,539 | 3,628 | +100 | +2.8% | 3,146,500 |
2021/12/06 | 3,625 | 3,645 | 3,490 | 3,528 | -148 | -4% | 2,851,700 |
2021/12/03 | 3,662 | 3,697 | 3,630 | 3,676 | +11 | +0.3% | 2,313,000 |
2021/12/02 | 3,646 | 3,688 | 3,630 | 3,665 | +31 | +0.9% | 2,596,100 |
851~
900
件表示中 / 3756件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
中外薬 | 743,000円 | +1.7% | +5.0% | 3.36% | 29.82倍 | 6.16倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
第一三共 | 364,700円 | +6.0% | +4.0% | 2.14% | 22.50倍 | 4.16倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
武 田 | 423,800円 | -1.1% | +75.3% | 4.72% | 29.36倍 | 0.97倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 754,600円 | +2.2% | +28.0% | 1.86% | 12.08倍 | 1.47倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 159,100円 | +0.9% | +380.2% | 4.90% | 21.92倍 | 1.88倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム